SS
VTVT icon

Sunbelt Securities’s vTv Therapeutics VTVT Stock Holding History

Sunbelt Securities’s Portfolio VTVT Stock Details VTVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$595 Hold
15
– – ﹤0.01% 2238
2025
Q4 		$600 Hold
15
– – ﹤0.01% 2197
2025
Q3 		$350 Hold
15
– – ﹤0.01% 2323
2025
Q2 		$207 Hold
15
– – ﹤0.01% 1747
2025
Q1 		$260 Hold
15
– – ﹤0.01% 1732
2024
Q4 		$210 Hold
15
– – ﹤0.01% 1752
2024
Q3 		$203 Hold
15
– – ﹤0.01% 1785
2024
Q2 		$265 Hold
15
– – ﹤0.01% 1694
2024
Q1 		$353 Hold
15
– – ﹤0.01% 1645
2023
Q4 		$172 Hold
15
– – ﹤0.01% 1645
2023
Q3 		$287 Hold
15
– – ﹤0.01% 1679
2023
Q2 		$444 Hold
15
– – ﹤0.01% 1590
2023
Q1 		$474 Buy
+15
New +$509 ﹤0.01% 1551

Other funds holding VTVT

SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
TECP
Trails Edge Capital Partners Atlanta, Georgia $437M AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

Sunbelt Securities's VTVT Position: Q1 2026 in Review

Sunbelt Securities held its vTv Therapeutics (VTVT) position steady in Q1 2026 at 15 shares worth $595. The position accounts for ﹤0.01% of the portfolio, ranked #2238.

Sunbelt Securities first reported a position in VTVT in Q1 2023 and has held it in 13 quarters since. The position peaked at $600 in Q4 2025. 35 funds tracked by Wall St. Rank hold VTVT as of Q1 2026.

  • Sunbelt Securities held 15 shares of vTv Therapeutics worth $595 as of Q1 2026.
  • Sunbelt Securities left its vTv Therapeutics share count unchanged in Q1 2026.
  • vTv Therapeutics made up ﹤0.01% of Sunbelt Securities's portfolio in Q1 2026, its #2238 holding.
  • Sunbelt Securities first reported a position in vTv Therapeutics in Q1 2023 and has held it in 13 quarters since.
  • Sunbelt Securities's vTv Therapeutics position peaked at $600 in Q4 2025.
  • 35 funds tracked by Wall St. Rank held vTv Therapeutics as of Q1 2026.

Based on Sunbelt Securities's 13F filing for Q1 2026, filed 18 May 2026.